title: Severe Elevation of Liver Enzymes Does Not Necessarily Require Treatment Interruption in Patients Treated With a Combination of Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for HCV Infection.
authors.affiliation: *Liver Unit Departments of †Gastroenterology §Internal Medicine B, Rambam Health Care Campus ‡Bruce Rappaport Faculty of Medicine Technion-Israel Institute of Technology Haifa, Israel.
authors.forename: Tarek
authors.initials: T
authors.lastname: Saadi
authors.forename: Johad
authors.initials: J
authors.lastname: Khoury
mesh_terms: D015081:2-Naphthylamine; D000410:Alanine Transaminase / Q000097:blood; D000813:Anilides / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D002219:Carbamates / Q000627:therapeutic use; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000201:enzymology*; D006801:Humans; D047029:Lactams, Macrocyclic; D047028:Macrocyclic Compounds / Q000627:therapeutic use; D008875:Middle Aged; D011392:Proline / Q000031:analogs & derivatives; D012254:Ribavirin / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D014633:Valine; D028761:Withholding Treatment
chemical_list: D000813:Anilides; D000998:Antiviral Agents; D002219:Carbamates; D003521:Cyclopropanes; D047029:Lactams, Macrocyclic; D047028:Macrocyclic Compounds; D013449:Sulfonamides; C586094:ombitasvir; D012254:Ribavirin; D014498:Uracil; D011392:Proline; D015081:2-Naphthylamine; C588260:dasabuvir; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D014633:Valine; D019438:Ritonavir; C585405:paritaprevir